Kazushi Suzuki
- Endocrinology top 1%
- Genetics top 2%
- Bacterial Genetics and Biotechnology 8
- Molecular Medicine top 5%
- Molecular Biology top 5%
- RNA and protein synthesis mechanisms 6
- Biotechnology top 5%
- Enzyme Production and Characterization 3
-
- Dementia and Cognitive Impairment Research 19
-
- Alzheimer's disease research and treatments 15
-
- Neuropeptides and Animal Physiology 4
-
- Health Systems, Economic Evaluations, Quality of Life 3
-
- Monoclonal and Polyclonal Antibodies Research 3
Kazushi Suzuki
61 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 137
- Endocrinology 489
- Genetics 963
- Molecular Medicine 138
- Molecular Biology 1.6k
- Biotechnology 151
Countries citing papers authored by Kazushi Suzuki
This map shows the geographic impact of Kazushi Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazushi Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazushi Suzuki more than expected).
Fields of papers citing papers by Kazushi Suzuki
This network shows the impact of papers produced by Kazushi Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazushi Suzuki. The network helps show where Kazushi Suzuki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kazushi Suzuki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 32 | |
| 7 | 2023 | 0 | |
| 8 | 2022 | 11 | |
| 9 | 2021 | 1 | |
| 10 | 2020 | 3 | |
| 11 | 2016 | 7 | |
| 12 | 2014 | 2 | |
| 13 | 2013 | 1 | |
| 14 | 2013 | 1 | |
| 15 | 2010 | 67 | |
| 16 | 2003 | 12 | |
| 17 | 2002 | 363 | |
| 18 | A hopeful prospect for genetic improvement of chronic disease resistance in swine. | 2001 | 4 |
| 19 | 1998 | 23 | |
| 20 | 1994 | 46 |
About Kazushi Suzuki
Kazushi Suzuki is a scholar working on Psychiatry and Mental health, Endocrinology and Physiology, having authored 67 papers that have together received 2.5k indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (19 papers), Alzheimer's disease research and treatments (15 papers), Bacterial Genetics and Biotechnology (8 papers), RNA and protein synthesis mechanisms (6 papers), Neuropeptides and Animal Physiology (4 papers), Enzyme Production and Characterization (3 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Endocrinology (489 citations), Genetics (963 citations) and Molecular Medicine (138 citations). Kazushi Suzuki has collaborated with scholars based in Japan, United States and Mexico. Frequent co-authors include Tony Romeo, Paul Babitzke, Carol S. Baker, Ashok K. Dubey, Dimitris Georgellis, L.X. Oakford, Jerry W. Simecka, Debra Jackson, Mark E. Hart and Sidney R. Kushner. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Genes & Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.